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Hereditary spherocytosis is relatively common, with an estimated frequency of 1 in 5000 individuals. Today, we know that is genetically 
heterogeneous, ranging from mild forms manifesting only in adulthood to severe forms that affect infants catastrophically2. 
This case illustrates a mild form of disease, which could go unnoticed particularly because of the absence of family history. So, we emphasize the 







A 29 years old man, with no significant past medical history, was referred to an  outpatient Internal Medicine’s clinic for: 
 Anemia (Hb 11,3g / dL, normocytic); 




 Asthenia in the previous year and half; 
 Progressively less tolerance to efforts. 
 
He denied: 
 Blood loss,  
 Itching,  
 Night sweats,  
 Change in color or consistency of stool,  
 Change in urine color or jaundice perception 
 Family history of anemia 
 
Physically:  
 pale,  
no cyanosis, 
 no palpable lymphadenopathy in different ganglion chains , 
 palpable mass in the upper left quadrant compatible with an increased  in spleen size. 
 
Laboratory investigation: 
 CBC confirmed normocytic anemia (Hb 12.3 g / dL) 
- - Hematocrit (30.2%) 
- - White  Blood cells (3,9x10x10 ^ 6 / uL)  
 Haptoglobin <8 mg / dL,  








Red blood cells 
anisocytosis, poiki- 
 
locytosis, with a predominance of spherocytes, "bite 
cells", slight polychromatophilic red cells, compatible with 
hemolytic anemia for intrinsic red blood cells pathology 
Osmotic fragility 









19,4cm of craniocaudal diameter and can be a hereditary 
spherocytosis  picture 
Marked splenomegaly 




Hereditary spherocytosis (HS) was described in 1871 and the first recorded splenectomy was performed soon after. It is the commonest cause of 
inherited chronic haemolysis in Northern Europe and North America with a quoted incidence of 1 in 5000 births. However, studies of osmotic fragility in 
blood donors suggest the existence of extremely mild or subclinical forms, raising the prevalence of HS to 1 in 20001. HS has also been found in other 
ethnic groups1. 
Hereditary spherocytosis (HS) is a heterogeneous group of disorders with regard to clinical severity, protein defects and mode of inheritance. It is 
relatively common in Caucasian populations; most affected individuals have mild or only moderate haemolysis1. 
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